AbbVie raised its 2025 profit forecast on Friday after strong sales of its newer immunology drugs Skyrizi and Rinvoq helped ...

The global neurology clinical trials market is poised for substantial growth over the next decade, with projections forecasting an increase in market size from USD 5.7 billion in 2022 to a remarkable ...

Fortrea Holdings Inc.’s FTRE share price has surged by 5.64%, which has investors questioning if this is right time to sell.

In the rapidly evolving landscape of oncology, precision is the cornerstone of progress. A leading biopharmaceutical company ...

LEXINGTON, KENTUCKY / ACCESS Newswire / April 24, 2025 / Today, NX Development Corp ("NXDC"), a Lexington, KY based life sciences company, announced the return of the sales and marketing rights for ...

With the threat of Trump administration's tariffs swirling and biopharma companies bracing for impact, many are announcing ...

Major drugmakers were a standout on a tumultuous day of corporate earnings on Thursday, beating expectations even as they ...